Literature DB >> 23559898

Induction of Potent Antigen-specific Cytotoxic T Cell Response by PLGA-nanoparticles Containing Antigen and TLR Agonist.

Young-Ran Lee1, Young-Hee Lee, Ki-Hyang Kim, Sun-A Im, Chong-Kil Lee.   

Abstract

Previously we showed that biodegradable nanoparticles containing poly-IC or CpG oligodeoxynucleotide (ODN) together with ovalbumin (OVA) were efficient at inducing MHC-restricted presentation of OVA peptides in dendritic cells. The CTL-inducing activities of the nanoparticles were examined in the present study. Nanoparticles containing poly-IC or CpG ODN together with OVA were prepared using biodegradable polymer poly(D,L-lactic acid-co-glycolic acid), and then were opsonized with mouse IgG. The nanoparticles were injected into the tail vein of mice, and 7 days later the OVA-specific CTL activities were measured using an in vivo CTL assay. Immunization of mice with the nanoparticles containing poly-IC or CpG ODN together with OVA elicited potent OVA-specific CTL activity compared to those containing OVA only. In accordance with these results, nanoparticles containing poly-IC or CpG ODN together with OVA exerted potent antitumor activity in mice that were subcutaneously implanted with EG7.OVA tumor cells. These results show that encapsulation of poly-IC or CpG ODN together with antigen in biodegradable nanoparticles is an effective approach for the induction of potent antigen-specific CTL responses in vivo.

Entities:  

Keywords:  Antitumor activity; CTL; CpG; Nanoparticle; PLGA; Poly-IC

Year:  2013        PMID: 23559898      PMCID: PMC3607708          DOI: 10.4110/in.2013.13.1.30

Source DB:  PubMed          Journal:  Immune Netw        ISSN: 1598-2629            Impact factor:   6.303


  19 in total

1.  Biodegradable nanoparticles containing TLR3 or TLR9 agonists together with antigen enhance MHC-restricted presentation of the antigen.

Authors:  Young-Ran Lee; Young-Hee Lee; Sun-A Im; In-Ho Yang; Ghe Whan Ahn; Kyungjae Kim; Chong-Kil Lee
Journal:  Arch Pharm Res       Date:  2010-11-30       Impact factor: 4.946

Review 2.  Cross-presentation: a general mechanism for CTL immunity and tolerance.

Authors:  F R Carbone; C Kurts; S R Bennett; J F Miller; W R Heath
Journal:  Immunol Today       Date:  1998-08

3.  Introduction of soluble protein into the class I pathway of antigen processing and presentation.

Authors:  M W Moore; F R Carbone; M J Bevan
Journal:  Cell       Date:  1988-09-09       Impact factor: 41.582

4.  Induction of cellular immunity to a mycobacterial antigen adsorbed on lamellar particles of lactide polymers.

Authors:  N Venkataprasad; A G Coombes; M Singh; M Rohde; K Wilkinson; F Hudecz; S S Davis; H M Vordermeier
Journal:  Vaccine       Date:  1999-04-09       Impact factor: 3.641

5.  Baccatin III, a synthetic precursor of taxol, enhances MHC-restricted antigen presentation in dendritic cells.

Authors:  Young-Hee Lee; Young-Ran Lee; Ki-Hyang Kim; Sun-A Im; Sukgil Song; Myung-Ku Lee; Youngsoo Kim; Jin Tae Hong; Kyungjae Kim; Chong-Kil Lee
Journal:  Int Immunopharmacol       Date:  2011-02-24       Impact factor: 4.932

6.  CD8- dendritic cells and macrophages cross-present poly(D,L-lactate-co-glycolate) acid microsphere-encapsulated antigen in vivo.

Authors:  Christopher Schliehe; Chiara Redaelli; Sabrina Engelhardt; Michael Fehlings; Marc Mueller; Nico van Rooijen; Marc Thiry; Kai Hildner; Horst Weller; Marcus Groettrup
Journal:  J Immunol       Date:  2011-07-27       Impact factor: 5.422

7.  Characterization of poly(D,L-lactic-co-glycolic acid) based nanoparticulate system for enhanced delivery of antigens to dendritic cells.

Authors:  Praveen Elamanchili; Manish Diwan; Min Cao; John Samuel
Journal:  Vaccine       Date:  2004-06-23       Impact factor: 3.641

Review 8.  Tumor-specific shared antigenic peptides recognized by human T cells.

Authors:  Pierre Van Der Bruggen; Yi Zhang; Pascal Chaux; Vincent Stroobant; Christophe Panichelli; Erwin S Schultz; Jacques Chapiro; Benoît J Van Den Eynde; Francis Brasseur; Thierry Boon
Journal:  Immunol Rev       Date:  2002-10       Impact factor: 12.988

9.  Dendritic cells process antigens encapsulated in a biodegradable polymer, poly(D,L-lactide-co-glycolide), via an alternate class I MHC processing pathway.

Authors:  Turmunkh Gerelchuluun; Young-Hee Lee; Young-Ran Lee; Sun-A Im; Sukgil Song; Jeong Sook Park; Kun Han; Kyungjae Kim; Chong-Kil Lee
Journal:  Arch Pharm Res       Date:  2007-11       Impact factor: 4.946

10.  Formulation and Characterization of Antigen-loaded PLGA Nanoparticles for Efficient Cross-priming of the Antigen.

Authors:  Young-Ran Lee; Young-Hee Lee; Sun-A Im; Kyungjae Kim; Chong-Kil Lee
Journal:  Immune Netw       Date:  2011-06-30       Impact factor: 6.303

View more
  10 in total

Review 1.  Peptide/protein vaccine delivery system based on PLGA particles.

Authors:  Mojgan Allahyari; Elham Mohit
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

2.  Tumor growth inhibition by mSTEAP peptide nanovaccine inducing augmented CD8+ T cell immune responses.

Authors:  Qiuqiang Chen; Ying Bao; Danielle Burner; Sharmeela Kaushal; Yu Zhang; Theresa Mendoza; Michael Bouvet; Cengiz Ozkan; Boris Minev; Wenxue Ma
Journal:  Drug Deliv Transl Res       Date:  2019-12       Impact factor: 5.671

3.  Processed Aloe vera gel ameliorates cyclophosphamide-induced immunotoxicity.

Authors:  Sun-A Im; Ki-Hyang Kim; Hee-Suk Kim; Ki-Hwa Lee; Eunju Shin; Seon-Gil Do; Tae Hyung Jo; Young In Park; Chong-Kil Lee
Journal:  Int J Mol Sci       Date:  2014-10-24       Impact factor: 5.923

4.  Co-delivery of Dual Toll-Like Receptor Agonists and Antigen in Poly(Lactic-Co-Glycolic) Acid/Polyethylenimine Cationic Hybrid Nanoparticles Promote Efficient In Vivo Immune Responses.

Authors:  Mahboubeh Ebrahimian; Maryam Hashemi; Mohsen Maleki; Gholamreza Hashemitabar; Khalil Abnous; Mohammad Ramezani; Alireza Haghparast
Journal:  Front Immunol       Date:  2017-09-13       Impact factor: 7.561

Review 5.  Harnessing Dendritic Cells for Poly (D,L-lactide-co-glycolide) Microspheres (PLGA MS)-Mediated Anti-tumor Therapy.

Authors:  Julia Koerner; Dennis Horvath; Marcus Groettrup
Journal:  Front Immunol       Date:  2019-04-05       Impact factor: 7.561

Review 6.  Nanoparticle-based vaccine development and evaluation against viral infections in pigs.

Authors:  Santosh Dhakal; Gourapura J Renukaradhya
Journal:  Vet Res       Date:  2019-11-06       Impact factor: 3.683

7.  Mutagenicity and Immune Toxicity of Emulsion-type Sausage Cured with Plasma-treated Water.

Authors:  Hyun-Joo Kim; Nak-Yun Sung; Hae In Yong; Hanwool Kim; Younggap Lim; Kwang Hyun Ko; Cheol-Heui Yun; Cheorun Jo
Journal:  Korean J Food Sci Anim Resour       Date:  2016-08-30       Impact factor: 2.622

Review 8.  Biodegradable Polymeric Nanoparticles-Based Vaccine Adjuvants for Lymph Nodes Targeting.

Authors:  Alice Gutjahr; Capucine Phelip; Anne-Line Coolen; Claire Monge; Anne-Sophie Boisgard; Stéphane Paul; Bernard Verrier
Journal:  Vaccines (Basel)       Date:  2016-10-12

9.  PLGA particulate subunit tuberculosis vaccines promote humoral and Th17 responses but do not enhance control of Mycobacterium tuberculosis infection.

Authors:  Anneliese S Ashhurst; Thaigarajan Parumasivam; John Gar Yan Chan; Leon C W Lin; Manuela Flórido; Nicholas P West; Hak-Kim Chan; Warwick J Britton
Journal:  PLoS One       Date:  2018-03-19       Impact factor: 3.240

10.  Human Salivary Histatin-1-Functionalized Gelatin Methacrylate Hydrogels Promote the Regeneration of Cartilage and Subchondral Bone in Temporomandibular Joints.

Authors:  Changjing Shi; Yu Yao; Lei Wang; Ping Sun; Jianying Feng; Gang Wu
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.